Moroccan medical device company Promamec has acquired a 51% stake in two German companies, NGPH and MyHerbliz, which specialize in cannabidiol (CBD) products. The remaining shares are retained by their historical shareholder, New Garden Pharma Limited. This acquisition, executed through its subsidiary LasoBio S.A., marks Promamec’s entry into the German CBD market and aligns with its st ...
Promamec qui a accueilli en juillet 2023 dans son tour de table, Vantage Capital, un des plus importants gestionnaires de fonds de dette mezzanine en Afrique, en lui cédant 49 % de l’entreprise pour 30 millions d’euros, vient d’acquérir deux sociétés allemandes, active dans le domaine des produits pharmaceutiques extraits du cannabis. A travers cette acquisition, le spécialiste marocain ...
Herbolea Biotech SpA ("Herbolea"), an Italian biotech company leader in the development of solventless extraction technologies, and Laso-Bio, a new biotech company affiliated to leading Maroccan healthcare company Promamec, are delighted to announce a strategic partnership and licensing agreement that will shape the nascent hemp and cannabis extraction industries in Morocco. Under this l ...
